177 related articles for article (PubMed ID: 10219981)
1. Repeated administration of delta9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat.
Corchero J; Manzanares J; Fuentes JA
Neuropharmacology; 1999 Mar; 38(3):433-9. PubMed ID: 10219981
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat.
Corchero J; Fuentes JA; Manzanares J
Life Sci; 1999; 64(11):905-11. PubMed ID: 10201639
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in proenkephalin gene expression response to delta9-tetrahydrocannabinol in the hypothalamus of the rat.
Corchero J; Fuentes JA; Manzanares J
J Psychopharmacol; 2002 Dec; 16(4):283-9. PubMed ID: 12503826
[TBL] [Abstract][Full Text] [Related]
4. Acute and repeated ECS treatment increases CRF, POMC and PENK gene expression in selected regions of the rat hypothalamus.
Garcia-Garcia L; Llewellyn-Jones V; Fernandez Fernandez I; Fuentes JA; Manzanares J
Neuroreport; 1998 Jan; 9(1):73-7. PubMed ID: 9592051
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain.
Manzanares J; Corchero J; Romero J; Fernandez-Ruiz JJ; Ramos JA; Fuentes JA
Brain Res Mol Brain Res; 1998 Mar; 55(1):126-32. PubMed ID: 9645967
[TBL] [Abstract][Full Text] [Related]
6. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors.
Schmidt ED; Aguilera G; Binnekade R; Tilders FJ
Neuroscience; 2003; 116(1):275-83. PubMed ID: 12535959
[TBL] [Abstract][Full Text] [Related]
7. Role of gonadal steroids in the corticotropin-releasing hormone and proopiomelanocortin gene expression response to Delta(9)-tetrahydrocannabinol in the hypothalamus of the rat.
Corchero J; Manzanares J; Fuentes JA
Neuroendocrinology; 2001 Sep; 74(3):185-92. PubMed ID: 11528220
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
[TBL] [Abstract][Full Text] [Related]
9. Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat.
Blasquez C; Jégou S; Friard O; Tonon MC; Fournier A; Vaudry H
Neuroscience; 1995 Sep; 68(1):221-7. PubMed ID: 7477927
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of expression of the corticotropin-releasing factor gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in rat pituitary.
Grino M; Young WS; Burgunder JM
Endocrinology; 1989 Jan; 124(1):60-8. PubMed ID: 2783310
[TBL] [Abstract][Full Text] [Related]
11. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
12. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats.
Jingami H; Matsukura S; Numa S; Imura H
Endocrinology; 1985 Oct; 117(4):1314-20. PubMed ID: 2992910
[TBL] [Abstract][Full Text] [Related]
13. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
[TBL] [Abstract][Full Text] [Related]
15. Stress-induced sensitization of the hypothalamic-pituitary adrenal axis is associated with alterations of hypothalamic and pituitary gene expression.
O'Connor KA; Ginsberg AB; Maksimova E; Wieseler Frank JL; Johnson JD; Spencer RL; Campeau S; Watkins LR; Maier SF
Neuroendocrinology; 2004; 80(4):252-63. PubMed ID: 15627803
[TBL] [Abstract][Full Text] [Related]
16. delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus.
Corchero J; Fuentes JA; Manzanares J
Eur J Pharmacol; 1997 Apr; 323(2-3):193-5. PubMed ID: 9128838
[TBL] [Abstract][Full Text] [Related]
17. Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone.
Kakucska I; Qi Y; Lechan RM
Endocrinology; 1995 Jul; 136(7):2795-802. PubMed ID: 7789304
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute stress on the expression of hypothalamic messenger ribonucleic acids encoding the endogenous opioid precursors preproenkephalin A and proopiomelanocortin.
Larsen PJ; Mau SE
Peptides; 1994; 15(5):783-90. PubMed ID: 7984495
[TBL] [Abstract][Full Text] [Related]
19. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.
Kim EM; Grace MK; Welch CC; Billington CJ; Levine AS
Am J Physiol; 1999 May; 276(5):R1320-6. PubMed ID: 10233022
[TBL] [Abstract][Full Text] [Related]
20. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat.
Schlussman SD; Zhou Y; Johansson P; Kiuru A; Ho A; Nyberg F; Kreek MJ
Neurosci Lett; 2000 Apr; 284(3):190-4. PubMed ID: 10773431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
